The Korean Journal of Sports Medicine

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2288-6028   pISSN 1226-3729

Table. 1.

Table. 1.

Participants characteristics (n=92)

Characteristic Adult CHD (n=46) Healthy control (n=46) z/χ2 p-value
Age (yr) 20.6±1.3 21.2±1.6 −1.868 0.065
Sex
Male 26 (56.5) 24 (52.2) 0.175 0.834
Female 20 (43.5) 22 (47.8)
Weight (kg) 59.2±12.5 63.1±11.0 −1.584 0.117
Body mass index (kg/m2) 21.9±3.5 22.0±2.4 −0.221 0.826
Medications, yes 31 (67.4)
No. of medications 1.6±1.7
Aspirin 24 (52.2)
β-blockers 12 (26.1)
ACEI/ARB 20 (43.5)
Diuretics 5 (10.9)
Anticoagulant 1 (2.2)
Left ventricle ejection fraction (%) 60.7±8.1
Poor (<30) 0 (0)
Mild decreased (30−50) 8 (17.4)
Normal (>50) 38 (82.6)
Arrhythmia, yes* 1 (2.2)
Pacemaker 1 (2.2)
Disease type
Simple (n=3)
Aortic valve stenosis 1 (2.2)
Atrial septal defect 1 (2.2)
Bicuspid aortic valve 1 (2.2)
Moderate (n=18)
AVSD 1 (2.2)
Coarctation of aorta 1 (2.2)
Congenital coronary aneurysm 1 (2.2)
Tetralogy of Fallot 15 (32.6)
Complex (n=25)
DORV 1 (2.2)
Fontan (functional single ventricle) 18 (39.1)
PA with VSD 4 (8.7)
Persistent truncus arteriosus 2 (4.3)

Values are presented as mean±standard deviation or number (%) unless otherwise indicated.

CHD: congenital heart disease, ACEI: angiotensin-converting enzyme inhibitor, ARB: angiotensin receptor blocker, AVSD: atrioventricular septal defect, DORV: double outlet right ventricle, PA: pulmonary atresia, VSD: ventricular septal defect.

*Bradycardia, tachycardia that require treatment, or nonsustain badycardia, tachycardia.

Korean J Sports Med 2020;38:225-33 https://doi.org/10.5763/kjsm.2020.38.4.225
© 2020 Korean J Sports Med